Infertility Testing Market Scope And Analysis

Report Code : TIPHE100001421
Category : Medical Device

No. of Pages : 150

Buy Now

Infertility Testing Market Analysis, Scope, and Growth by 2030

Buy Now

Infertility Testing Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 424.20 Million
Market Size by 2030	US$ 820.08 Million
Global CAGR (2022 - 2030)	8.6%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Type Male Infertility Testing and Female Infertility Testing By Test Kits Human Follicular Stimulating Hormone Test Kits Human Chorionic Gonadotropin Hormone Test Kits Luteinizing Hormone Test Kits By Sample Blood Urine By End User Hospitals & Clinics Fertility Centers Homecare
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Merck KgaA Procter Gamble bioMerieux SA Alere Inc Babystart Ltd bioZhena Corporation Quidel Corporation CENTOGENE N V SCSA Diagnostics Inc

Industry Developments and Future Opportunities:

The infertility testing market forecast can help stakeholders in this marketplace plan their growth strategies. As per the press releases by leading players operating in the market, a few strategic developments are listed below:

In July 2023, 2San, a respected global leader in self-diagnostic testing, partnered with Proov to launch its exclusive, easy-to-use at-home fertility tests at hand-selected Hy-Vee stores in eight Midwestern states.
In January 2022, Kindbody, a leading fertility and family-building care provider, introduced Kind at Home, its consumer products division dedicated to support people throughout their reproductive journey. The initiative began with the introduction of user-friendly home fertility hormone tests for women and men.
In December 2021, Carrot Fertility announced the launch of a new kit to help people monitor fertility hormones and related biomarkers at home. A customized, testing kit provides a more comprehensive picture of fertility health, enabling earlier action and interventions from the comfort of home.

Competitive Landscape and Key Companies:

Merck KgaA; Procter & Gamble; bioMerieux SA; Alere Inc.; Babystart Ltd.; bioZhena Corporation; Quidel Corporation; CENTOGENE N.V.; SCSA Diagnostics, Inc.; and Boditech Med Inc. are among the prominent companies profiled in the infertility testing market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to fulfil the growing consumer demand across the world.